Stay updated on Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor update with no visible impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedExpanded the Locations section with a global list of trial sites (US, Argentina, Austria, etc.) and removed several previously listed sites. This update changes where participants can enroll in the study.SummaryDifference2%

- Check56 days agoChange DetectedAdded a note that PubMed publications are automatically filled and may not be about the study, and updated the page revision to v3.3.2 (previously v3.2.0).SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Tainan, Taiwan, 71004 as a study location and removed Tainan City, Taiwan, 71004 to standardize the listing.SummaryDifference0.1%

- Check77 days agoChange DetectedNo substantive content changes were detected in the Study Details page between the screenshots. The differences appear to be layout/UI adjustments rather than additions or deletions of information.SummaryDifference0.2%

- Check106 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

Stay in the know with updates to Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.